Ysios Capital
Finance · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Travessera De Gràcia 11 Planta 8, Barcel...Phone Number
+34 935173545Website
www.ysioscapital.comRevenue
$5.3 MillionIndustry
About Ysios Capital
Ysios Capital Org Chart
Is Ysios Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Ysios Capital recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ysios Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Ysios Capital launches new products
Ysios Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Ysios Capital is spiking on competitors!
Funding: Get notified immidiatlly once Ysios Capital has new funding data
Congratulate Masked Content for being promoted to Masked Content at Ysios Capital
Website visits: Recent activity has been detected on your website
Click to see if Ysios Capital had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Ysios Capital as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Ysios Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Ysios Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Ysios Capital.
Ysios Capital Tech Stack
A closer look at the technologies used by Ysios Capital
Most Recent Scoops
Ysios Capital News & Media
Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates (ADCs) and immunomodulators, as well as...Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates (ADCs) and immunomodulators, as well as...
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ysios Capital
Ysios Capital is a leading life sciences venture capital firm that invests in highly innovative biotechnology companies worldwide. The firm provides resources to biotech ventures focused on developing novel therapies for high unmet medical needs, aiming to positively impact patients and society. With a diverse and experienced team, Ysios Capital ha... Read More